A key factor driving the growth of the market is increased demand for cell RNA detection in biotechnology. Cell RNA detection is generally used for clinical purposes. However, cell RNA detection is gaining traction in the biotechnology sector for various purposes such as cell engineering, protein engineering, and physiological research.
This market research report on the global cell RNA detection market 2018-2022 also provides an analysis of the most important trends expected to impact the market outlook during the forecast period. Technavio classifies an emerging trend as a major factor that has the potential to significantly impact the market and contribute to its growth or decline.
This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing
In this report, Technavio highlights the growing opportunity in developing nations as one of the key emerging trends in the global cell RNA detection market:
Global cell RNA detection market: Growing opportunity in developing nations
Emerging economies provide huge growth opportunities due to extensive government support and significant R&D investments by the leading vendors. This is due to their focus on improving the cell-based research.
“Countries such as China, India, Mexico, and Brazil offer growth opportunities due to the availability of affordable instruments that are used in cell-based research. These countries have already spent more on R&D in comparison to European nations. The increased fund allocation allows for the easy procurement of cell RNA detection products that are needed for cell-based research by the end users in the market,” says a senior analyst at Technavio.
Global cell RNA detection market: Segmentation analysis
This market research report segments the global cell RNA detection market by end-user (pharmaceutical and biotechnology companies, research and academic institutes and others) and geographical regions (APAC, EMEA, and the Americas).
The Americas led the market in 2017 with a market share of close to 40%, followed by APAC and EMEA respectively. North America is a major contributor in the region. The market in the Americas is majorly driven by factors such as rapid increasing infectious diseases demanding the need of antibiotics and other drugs and increasing the use of cell-based products which require cell RNA detection to treat various chronic diseases such as cancer, tuberculosis, diabetes, and cardiovascular diseases.
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Some of the key topics covered in the report include:
- Market ecosystem
- Market characteristics
- Market segmentation analysis
- Market definition
- Market size and forecast
Five Forces Analysis
- Regional comparison
- Key leading countries
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Competitive scenario
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at email@example.com.